Andrea Marengo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Patients with inactive or occult hepatitis B virus infection and onco-hematological malignancies are at risk of hepatitis flare, hepatic failure and death due to chemotherapy-mediated reactivation. Nucleot(s)ide analogues can reduce reactivation risks and/or hepatitis. However, immuno-mediated phenomena combine to determine liver damage and clinical(More)
  • 1